Correlation Between Terns Pharmaceuticals and Solid Biosciences
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Solid Biosciences LLC, you can compare the effects of market volatilities on Terns Pharmaceuticals and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Solid Biosciences.
Diversification Opportunities for Terns Pharmaceuticals and Solid Biosciences
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Terns and Solid is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Solid Biosciences go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Solid Biosciences
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Solid Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Terns Pharmaceuticals is 1.17 times less risky than Solid Biosciences. The stock trades about -0.1 of its potential returns per unit of risk. The Solid Biosciences LLC is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 552.00 in Solid Biosciences LLC on September 1, 2024 and sell it today you would earn a total of 18.00 from holding Solid Biosciences LLC or generate 3.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Solid Biosciences LLC
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Solid Biosciences LLC |
Terns Pharmaceuticals and Solid Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Solid Biosciences
The main advantage of trading using opposite Terns Pharmaceuticals and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.| Terns Pharmaceuticals vs. Crinetics Pharmaceuticals | Terns Pharmaceuticals vs. Enanta Pharmaceuticals | Terns Pharmaceuticals vs. Amicus Therapeutics | Terns Pharmaceuticals vs. Connect Biopharma Holdings |
| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |